Brainstorm Cell TherapeuticsBCLI

13F holders, Q1 2024 (March 31)
47holders
$0.54avg. 13F price*

At the end of Q1 2024, 47 institutions reported holding Brainstorm Cell Therapeutics (BCLI) in their 13F filings. The largest holders were Vanguard Group Inc. ($791K), BlackRock Inc. ($276K) and Geode Capital Management, LLC ($202K).

Company
Brainstorm Cell Therapeutics
CUSIP
10501E201
Latest filing quarter
Q4 2024

History

Number of 13F holders

01020304050 Q1 2024: 47Q1 2024Q2 2024: 48Q2 2024Q3 2024: 34Q3 2024Q4 2024: 3Q4 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions7$123K
Exits6$33K

Ownership 47 holders

Vanguard Group Inc. 0.00% Reduce -1.6% 1,400,993 $791K
BlackRock Inc. 0.00% Add +4.9% 489,313 $276K
Geode Capital Management, LLC 0.00% No change 357,041 $202K
Liberty Wealth Management LLC 0.04% No change 340,150 $192K
Weaver Consulting Group 0.04% No change 199,356 $113K
Abner Herrman & Brock LLC 0.01% No change 145,500 $82K
Raymond James & Associates 0.00% Reduce -1.7% 113,785 $64K
Gsa Capital Partners LLP 0.01% New 111,234 $63K
State Street Corp. 0.00% No change 96,060 $54K
Ikarian Capital, LLC 0.01% No change 90,242 $51K
Kingswood Wealth Advisors, LLC 0.01% New 81,050 $46K
Jmac Enterprises LLC 0.01% No change 65,430 $37K
Northern Trust Corp. 0.00% No change 54,788 $31K
Morgan Stanley 0.00% Reduce -22.1% 40,098 $23K
Group One Trading LLC 0.00% Add +27.5% 30,654 $17K
Wells Fargo & Company 0.00% Reduce -2.6% 29,110 $16K
Susquehanna International Group, LLP 0.00% Add +6.9% 26,544 $15K
Creative Planning 0.00% Add +3.4% 21,726 $12K
Janney Montgomery Scott LLC 0.00% No change 20,500 $12K
Saxony Capital Management, LLC 0.01% Reduce -0.9% 20,950 $12K
Jane Street Group, LLC 0.00% New 18,732 $11K
Professional Financial Advisors, LLC 0.00% No change 17,279 $10K
First Affirmative Financial Network 0.01% Reduce -2.7% 15,278 $9K
Avior Wealth Management, LLC 0.00% No change 12,686 $7K
Socha Financial Group, LLC 0.00% No change 12,380 $7K
Bank of New York Mellon Corp 0.00% No change 11,994 $7K
Tower Research Capital LLC (TRC) 0.00% Reduce -39.6% 11,005 $6K
Osaic Holdings, Inc. 0.00% Reduce -2.0% 10,519 $6K
Cypress Capital Management LLC (WY) 0.01% No change 10,000 $6K
Institutional & Family Asset Management, LLC 0.00% No change 6,000 $3K
Steward Partners Investment Advisory, LLC 0.00% No change 4,200 $2K
Bangor Savings Bank 0.00% No change 4,000 $2K
Simplex Trading, LLC 0.00% New 4,039 $2K
UBS Group AG 0.00% No change 2,500 $1K
Balefire, LLC 0.00% No change 1,944 $1K
Clearstead Advisors, LLC 0.00% New 1,500 $822
EverSource Wealth Advisors, LLC 0.00% No change 2,128 $803
Cranbrook Wealth Management, LLC 0.00% New 1,000 $565
Bank of America Corp. 0.00% Reduce -5.1% 1,000 $564
St Germain D J Co. Inc. 0.00% No change 500 $282
BNP Paribas Financial Markets 0.00% No change 364 $206
Westside Investment Management, Inc. 0.00% No change 200 $112
CoreCap Advisors, LLC 0.00% New 133 $75
JPMorgan Chase & Co. 0.00% Add +49.3% 106 $60
Mark Sheptoff Financial Planning, LLC 0.00% No change 100 $56
Caldwell Sutter Capital, Inc. 0.00% No change 157,009 $0
Royal Bank of Canada 0.00% Reduce -41.7% 317 $0

"% of holder's portfolio" is BCLI's weight in each manager's 13F, not the share of Brainstorm Cell Therapeutics the manager owns.